A Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyposis (CROWNS-2)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This is a multi-center, randomized, double blind, placebo-controlled Phase III study to evaluate the efficacy and safety of CM310, and to observe the life quality of subjects, the Pharmacokinetics, Pharmacodynamics and immumogenicity of CM310 in patients with chronic rhinosinusitis with nasal polyposis (CRSwNP).
Epistemonikos ID: 44708d1012eb7b80eda2a929f475768e33bc458b
First added on: May 13, 2024